FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21969411000001109: Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Mar 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
73005401000001118 Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
73005501000001119 Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) Is a Mercaptopurine 100mg/5ml oral suspension true Inferred relationship Existential restriction modifier
Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) Has active ingredient Mercaptopurine true Inferred relationship Existential restriction modifier
Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) Has specific active ingredient Mercaptopurine true Inferred relationship Existential restriction modifier
Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) Has excipient Aspartame false Inferred relationship Existential restriction modifier
Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) Is a Xaluprine true Inferred relationship Existential restriction modifier
Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) Has manufactured dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) 100 ml Has AMP True Xaluprine 20mg/ml oral suspension (Nova Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start